ArticleCost effectiveness and resource allocation : C/E2017

Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece.

Hara Kousoulakou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.